FOUSE JACQUALYN A — SEC Form 4 filings
SEC reporting owner CIK 1405288. 14 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-01-09 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 34,401 shares, $833,748 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: sale of 10,722 shares @ $21.64 ($232,024) in AGIOS PHARMACEUTICALS, INC., filed 2024-01-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | 8 | — | 4 legs · 34,401 sh · $833,748 | 20 |
| INCYTE CORP (INCY) | Director | 3 | — | — | 6 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Director | 3 | — | — | 6 |
Form 4 filings — FOUSE JACQUALYN A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 2,816 @ $0 · Option exercise (M): 2,816 (derivative) @ $0 · Grant/award (A): 2,927 (derivative) @ $0 · Grant/award (A): 14,950 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 454 @ $0 · Grant/award (A): 766 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | INCYTE CORP (INCY) | Grant/award (A): 1,642 @ $0 · Grant/award (A): 6,111 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 203 @ $0 · Grant/award (A): 366 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 2,120 @ $0 · Grant/award (A): 2,816 (derivative) @ $0 · Grant/award (A): 15,768 (derivative) @ $0 · Option exercise (M): 2,120 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | INCYTE CORP (INCY) | Grant/award (A): 2,518 @ $0 · Grant/award (A): 9,216 (derivative) @ $0 | EDGAR |
| 2025-04-10 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 15,933 @ $0 · Sale (S): 7,497 @ $25.90 · Option exercise (M): 15,933 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/award (A): 894 @ $0 · Grant/award (A): 1,579 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Grant/award (A): 2,120 (derivative) @ $0 · Grant/award (A): 11,774 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 3,388 @ $0 · Option exercise (M): 3,388 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | INCYTE CORP (INCY) | Grant/award (A): 2,830 @ $0 · Grant/award (A): 12,517 (derivative) @ $0 | EDGAR |
| 2024-04-10 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 15,934 @ $0 · Sale (S): 7,791 @ $27.55 · Option exercise (M): 15,934 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 23,900 @ $0 · Sale (S): 10,722 @ $21.64 · Option exercise (M): 23,900 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 17,500 @ $0 · Sale (S): 8,391 @ $22.99 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1405288 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →